Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 494.00
Bid: 488.00
Ask: 500.00
Change: 5.00 (1.02%)
Spread: 12.00 (2.459%)
Open: 489.00
High: 494.00
Low: 489.00
Prev. Close: 489.00
BPM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Realisation of Investment

7 Dec 2023 07:23

RNS Number : 0138W
B.P. Marsh & Partners PLC
07 December 2023
 

7 December 2023

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

Realisation of investment

 Sale of Paladin Holdings Limited, parent company of CBC UK Limited

 

B.P. Marsh and Partners Plc (AIM:BPM), the specialist private equity investor in early stage financial services businesses, is pleased to announce the sale of its entire shareholding in Paladin Holdings Limited ("Paladin"), the holding company of CBC UK Limited ("CBC"), subject to certain conditions including regulatory approval being granted.

 

Highlights:

· £41.8m (net of all transaction costs) initial cash consideration expected to be received from the disposal of the Group's 43.8% holding in Paladin on completion, subject to regulatory approval

· Internal rate of return to B.P. Marsh of 45% (inclusive of all income and fees) based on initial consideration

· Repayment to the Group of £5.9m outstanding loans to Paladin

· £11.3m uplift from £30.53m valuation as at 31 July 2023

· Potential for £17.8m further consideration if Paladin achieves defined hurdles

· Initial equity investment of £3.5k

 

Sale of Shareholding in Paladin

 

B.P. Marsh has agreed to sell its shareholding in Paladin, the parent company of CBC, the London-based Insurance Broker, to Specialist Risk Group Limited ("SRG"), one of the fastest growing groups of insurance intermediaries in the UK, subject to regulatory approval. SRG is backed by HGGC, the Californian based mid-market private equity firm.

 

Background to the Investment

 

B.P. Marsh originally invested in Paladin as part of a Management Buy-Out in February 2017, with an initial equity investment of £3.5k for a 35% shareholding. The Company has also supported Paladin with loan funding during this time, and currently has outstanding debt of £5.9m. Since B.P. Marsh's investment, Paladin's EBITDA has grown from a loss of £(50)k in 2016 to a forecast adjusted EBITDA of £10m in FY23. In the year ended 31 January 2023, Paladin contributed £0.9m to the Group's total income from investments.

 

The Transaction

 

Upon completion, the Group expects to receive at least £41.8m in cash (net of all transaction costs) plus repayment in full of its £5.9m loans to Paladin, an aggregate cash receipt of £47.7m. The equity proportion of the initial consideration alone represents an £11.3m uplift (or 37%) on the Group's most recent £30.53m valuation of the investment as at 31 July 2023, underlining our valuation methodology.

 

As well as the initial consideration on completion, the Company will also be entitled to receive its proportion of any net working capital adjustment, expected to be finalised within three months of completion.

 

The Company will then be entitled to receive deferred consideration of up to £17.8m in cash based upon 20% EBITDA growth targets above Paladin's current EBITDA in FY24 and FY25, payable in 2025 and 2026. There is the possibility of further consideration in FY25 should Paladin outperform these growth targets.

 

Jon Newman, the Company's Finance Director and Nominee Director on the Boards of Paladin and CBC, will resign from his roles at Paladin and CBC on completion of the sale.

 

The investment, development and subsequent sale of the Group's holding in Paladin demonstrates B.P. Marsh's established strategy of partnering with entrepreneurial management teams to assist their growth prior to reaching a management-led exit in a time frame that suits all parties.

 

Jon Newman, the Group's Finance Director, commented:

 

"The sale of our stake in Paladin at an expected IRR of 45% at completion with the potential for significant further consideration over the next two years, is testament to our investment strategy and ability to identify opportunities to back successful management teams and to successfully realise value for our shareholders. We believe that there are few, if any, UK investors that could have made this investment, demonstrating the specialist position that B.P. Marsh occupies in the marketplace and the opportunities that this can provide our investors.

 

"It has been an absolute pleasure to work with Andrew Wallas, Rob Cottingham and the whole team at CBC and be a part of the transformational growth since the MBO almost seven years ago. This deal offers an exciting future for both SRG and CBC, and the whole of B.P. Marsh wishes everyone at CBC every success in the future."

 

Andrew Wallas, Chairman of CBC, said:

 

"When Rob Cottingham called me in 2016 to explain the opportunity for a Management Buyout of independent Lloyd's Broker CBC, I contacted B.P. Marsh, who agreed to partner with us very readily. This year is the 50th anniversary of me commencing my career within the Lloyd's market as a junior administrator with Nelson Hurst under the tutelage of Brian Marsh. B.P. Marsh has provided follow on funding and supported us to expand the business by attracting highly experienced, talented and dedicated practitioners.

 

"The B.P. Marsh nominee director on our board, Jon Newman, has provided us with insight, inspiration, wise council and a calming influence which has been invaluable to us as we have developed the business under the leadership of Rob Cottingham. The role and expertise of B.P. Marsh and in particular Jon Newman in helping us to navigate this transaction has been deeply appreciated by both Rob Cottingham and myself."

 

Use of Proceeds

 

Subject to completion, this transaction would increase the Group's current funds to approximately £93.7m after transaction costs and tax. Following the receipt of the Sales proceeds, the Directors will present their plans for the utilisation of this cash to Shareholders.

 

Note

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Stephen Jones / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fourteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for approaching ten years.

 

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISGRBDDCBGDGXR
Date   Source Headline
16th Apr 202412:45 pmRNSInvestee Company Update – LEBC Holdings
12th Apr 202411:01 amRNSAward of Shares under Share Incentive Plan
9th Apr 20249:45 amRNSInvestment Update – Pantheon Specialty Limited
8th Apr 20243:07 pmRNSTransfer of Treasury Shares
27th Mar 202412:20 pmRNSInvestment – Devonshire UW Limited
25th Mar 20247:00 amRNSCompletion of Sale and Dividend Declaration
22nd Feb 202410:49 amRNSDirector/PDMR Shareholding
19th Feb 20244:05 pmRNSDirector/PDMR Shareholding
19th Feb 20247:00 amRNSTrading Update
16th Feb 20244:13 pmRNSDirector/PDMR Shareholding
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
13th Feb 20241:52 pmRNSHolding(s) in Company
9th Feb 20249:25 amRNSDirector/PDMR Shareholding
7th Feb 20243:00 pmRNSInterim Dividend Declaration
6th Feb 202412:31 pmRNSDirector/PDMR Shareholding
23rd Jan 20242:23 pmRNSUse of Proceeds of Sale and Strategy Confirmation
4th Jan 20244:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:25 amRNSInvestment – Ai Marine Risk Limited
27th Dec 20237:00 amRNSCorrection - PDMR and Director Dealings
8th Dec 20235:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:23 amRNSRealisation of Investment
4th Dec 202310:58 amRNSTransaction in Own Shares
30th Nov 202312:56 pmRNSTransaction in Own Shares
29th Nov 20232:29 pmRNSTransaction in Own Shares
27th Nov 202312:48 pmRNSTransaction in Own Shares
24th Nov 20234:15 pmRNSTransaction in Own Shares
23rd Nov 20234:55 pmRNSTransaction in Own Shares
20th Nov 202312:35 pmRNSFurther Information re Share Option Plan
20th Nov 202311:44 amRNSTransaction in Own Shares
15th Nov 20235:33 pmRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNSShares Cancellation & New Share Buy-Back Programme
13th Nov 20239:42 amRNSInvestee Company Update disposal by LEBC of Aspira
20th Oct 20236:23 pmRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSHalf-Year Results
11th Oct 20234:05 pmRNSNotice of Half Year Results
10th Oct 20237:00 amRNSCompletion of Sale of Kentro Capital Limited
2nd Oct 202312:05 pmRNSTransaction in Own Shares
25th Sep 202310:28 amRNSTransaction in Own Shares
19th Sep 20233:50 pmRNSTransaction in Own Shares
18th Sep 202311:18 amRNSTransaction in Own Shares
18th Sep 20237:00 amRNSTrading Statement
14th Sep 20232:49 pmRNSTransaction in Own Shares
11th Sep 20234:29 pmRNSTransaction in Own Shares
7th Sep 20235:32 pmRNSTransaction in Own Shares
5th Sep 20234:24 pmRNSTransaction in Own Shares
4th Sep 20232:48 pmRNSTransaction in Own Shares
1st Sep 20233:13 pmRNSTransaction in Own Shares
30th Aug 20231:58 pmRNSTransaction in Own Shares
29th Aug 20239:03 amRNSTransaction in Own Shares
24th Aug 202312:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.